Skip to main content
. 2015 Jun 4;10(6):e0128202. doi: 10.1371/journal.pone.0128202

Table 3. Univariate logistic regression model associations between KRAS mutation status and MMR status.

pMMR-Mutant KRAS dMMR-Mutant KRAS
Characteristics OR (95% CI) P OR (95% CI) P
 Female (referent: male) 1.85 (1.39 to 2.46) <0.0001 0.56 (0.20 to 1.57) 0.37
 Proximal (referent: distal) 2.00 (1.30 to 3.08) 0.002 1.63 (0.48 to 5.50) 0.43
 Proximal (referent: Rectum) 1.31 (0.89 to 1.93) 0.17 0.54 (0.10 to 3.02) 0.76
 pT 3–4 (referent: pT 1–2) 1.14 (0.75 to 1.72) 0.54 0.27 (0.06 to 1.19) 0.15
 pN 1–2 (referent: pN 0) 1.48 (1.11 to 1.96) 0.007 0.67 (0.24 to 1.82) 0.43
 Low grade (referent: moderate to high grade) 0.81 (0.56 to 1.18) 0.28 0.51 (0.18 to 1.48) 0.22
 Mucinous (referent: non-mucinous) 1.50 (1.11 to 2.01) 0.007 1.61 (0.58 to 4.53) 0.36
 pTNM III–IV (referent: pTNM I–II) 1.38 (1.04 to 1.83) 0.03 0.78 (0.29 to 2.11) 0.63
 Age ≥ 50 years (referent: < 50 years) 1.38 (0.98 to 1.94) 0.06 0.63 (0.23 to 1.69) 0.35
 Tumor size < 6cm (referent: ≥ 6cm) 1.09 (0.78 to 1.54) 0.61 0.71 (0.26 to 1.92) 0.50

CI = confidence interval; dMMR = deficient mismatch repair; pMMR = proficient mismatch repair; OR = odds ratio.

= Two-sided χ2 test with continuity correction

§ Fischer’s exact test

Others are two-sided χ2 test.

A P value for significance was adjusted for multiple hypothesis testing to P = 0.05/6 = 0.0083. Thus, a P value between 0.05 and 0.0083 should be regarded as of borderline significance.